Aranding, Baby Boy .

HRN: 21-99-44  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/26/2022
11/02/2022
IVTT
47mg
Q24h
PSNB (Maternal UTI)
Waiting Final Action 
10/26/2022
AMPICILLIN 500MG (VIAL)
10/26/2022
11/02/2022
IVTT
155mg
Q12h
PSNB (maternal UTI)
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: